| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $160K | -54.2% |
| SG&A Expense | $1.9M | +1548.5% |
| Operating Income | -$5.0M | -605.1% |
| Income Tax | $0 | — |
| Net Income | -$9.1M | -1144.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7K | -94.5% |
| Current Assets | $313K | +125.3% |
| Total Assets | $423K | +156.5% |
| Current Liabilities | $1.1M | +1175.2% |
| Total Liabilities | $1.1M | +47.2% |
| Stockholders' Equity | -$648K | -15.1% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | -130.5% |
| Investing Cash Flow | -$1.1M | -360.0% |
| Financing Cash Flow | $2.2M | +143.9% |